Treatment with Low-Dose Danazol in Livedo Vasculitis / 대한피부과학회지
Korean Journal of Dermatology
;
: 163-167, 1999.
Artigo
em Coreano
| WPRIM
| ID: wpr-93009
ABSTRACT
BACKGROUND:
Several modalities have been used for the treatment of livedo vasculitis. However, in some cases conspicious morbidity is caused by recurrent painful ulceration resistant to therapy.OBJECTIVE:
This study was conducted to determine the effectiveness and adverse effects of the danazol in treatment of livedo vasculitis.METHODS:
Nine patients with ulcerative lesions due to livedo vasculitis were included for danazol therapy. Danazol 200mg was administered daily for 4 to 8 weeks.RESULTS:
Eight of the patients showed remarkable improvement and were satisfied with this therapy. Significant adverse effects were not observed.CONCLUSION:
We suggest that a low dose of danazol may be considered as the first line of treatment and is worthwhile to try in cases recalcitrant to the other treatment.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Úlcera
/
Vasculite
/
Danazol
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
1999
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS